Proto Script Pharmaceutical Corp
OTC:PSCR
Cash Flow Statement
Cash Flow Statement
Proto Script Pharmaceutical Corp
| May-2012 | Aug-2012 | Nov-2012 | Feb-2013 | May-2013 | Aug-2013 | Nov-2013 | Feb-2014 | May-2014 | Aug-2014 | Nov-2014 | Feb-2015 | May-2015 | Aug-2015 | Nov-2015 | Feb-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(7)
|
(8)
|
(8)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
7
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+16%
|
(0)
-50%
|
(0)
N/A
|
(0)
-7%
|
(0)
-25%
|
(0)
+50%
|
(0)
N/A
|
(0)
-63%
|
(0)
+8%
|
(0)
-33%
|
(0)
-25%
|
(0)
+9%
|
(0)
+12%
|
(0)
+25%
|
(0)
+67%
|
(0)
-282%
|
0
N/A
|
0
+1 278%
|
(0)
N/A
|
(0)
-85%
|
(0)
+4%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-407%
|
(0)
-62%
|
(0)
-48%
|
(0)
+7%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
-18%
|
0
+300%
|
0
N/A
|
0
-3%
|
0
+3%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
0
+10%
|
0
-9%
|
0
-33%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-886%
|
0
N/A
|
0
+37%
|
0
0%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-10%
|
0
-11%
|
(0)
N/A
|
(0)
N/A
|
(0)
-63%
|
(0)
+8%
|
(0)
N/A
|
(0)
+33%
|
(0)
+38%
|
(0)
+20%
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-70%
|
0
N/A
|
(0)
N/A
|
(0)
+70%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+16%
|
(0)
-50%
|
(0)
N/A
|
(0)
-7%
|
(0)
-25%
|
(0)
+50%
|
(0)
N/A
|
(0)
-63%
|
(0)
+8%
|
(0)
-33%
|
(0)
-25%
|
(0)
+9%
|
(0)
+12%
|
(0)
+25%
|
(0)
+67%
|
(0)
-282%
|
0
N/A
|
0
+14 350%
|
(0)
N/A
|
(0)
-80%
|
(0)
+4%
|
|